4990 — Showa Chemical Industry Co Balance Sheet
0.000.00%
- ¥5bn
- ¥5bn
- ¥9bn
- 65
- 74
- 42
- 68
Annual balance sheet for Showa Chemical Industry Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 3,109 | 3,249 | 2,993 | 3,149 | 3,172 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 2,111 | 2,337 | 2,811 | 2,696 | 2,446 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,253 | 6,533 | 6,893 | 6,985 | 6,790 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2,696 | 2,597 | 2,530 | 2,489 | 2,613 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,322 | 12,614 | 13,040 | 13,528 | 13,655 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 4,380 | 4,488 | 4,388 | 4,187 | 3,666 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 6,548 | 6,492 | 6,284 | 5,929 | 5,536 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,774 | 6,122 | 6,756 | 7,599 | 8,120 |
| Total Liabilities & Shareholders' Equity | 12,322 | 12,614 | 13,040 | 13,528 | 13,655 |
| Total Common Shares Outstanding |